Frazier Life Sciences Management, L.P. 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Frazier Life Sciences Management, L.P. disclosed 53 US equity positions worth $2.5bn in its Q3 2024 13F filing. The largest position was MIRM at 10.3% of the reported book, followed by NEWAMSTERDAM PHARMA COMPANY and PHAT.
What did Frazier Life Sciences Management, L.P. own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | MIRM MIRUM PHARMACEUTICALS INC | Healthcare | 10.3% | $256.2m | 6,570,392 | – | |
| 2 | NEWAMSTERDAM PHARMA COMPANY | 8.6% | $213.4m | 12,855,194 | – | ||
| 3 | PHAT PHATHOM PHARMACEUTICALS INC | 7.3% | $182.8m | 10,109,279 | – | ||
| 4 | KRYS KRYSTAL BIOTECH INC | Healthcare | 7.2% | $179.9m | 988,460 | – | |
| 5 | MBX MBX BIOSCIENCES INC | Healthcare | 6.2% | $155.5m | 5,985,347 | – | |
| 6 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 5.1% | $126.6m | 2,416,952 | – | |
| 7 | PCVX VAXCYTE INC | Healthcare | 4.0% | $100.5m | 879,405 | – | |
| 8 | VRNA VERONA PHARMA PLC | 3.9% | $97.4m | 3,383,950 | – | ||
| 9 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 3.8% | $95.7m | 3,760,457 | – | |
| 10 | IRON DISC MEDICINE INC | Healthcare | 3.5% | $86.2m | 1,754,834 | – | |
| 11 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 3.3% | $81.7m | 8,785,284 | – | |
| 12 | EWTX EDGEWISE THERAPEUTICS INC | 3.0% | $75.6m | 2,832,867 | – | ||
| 13 | ANAB ANAPTYSBIO INC | Healthcare | 3.0% | $74.0m | 2,209,189 | – | |
| 14 | ERAS ERASCA INC | Healthcare | 2.1% | $52.9m | 19,391,687 | – | |
| 15 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 2.1% | $52.2m | 1,587,527 | – | |
| 16 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.9% | $46.4m | 1,044,154 | – | |
| 17 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.8% | $45.2m | 997,455 | – | |
| 18 | SLNOEUR SOLENO THERAPEUTICS INC | 1.8% | $44.2m | 875,667 | – | ||
| 19 | 4XC1 KALVISTA PHARMACEUTICALS INC | 1.7% | $42.7m | 3,687,867 | – | ||
| 20 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 1.7% | $42.5m | 4,142,855 | – | |
| 21 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.4% | $35.2m | 633,715 | – | |
| 22 | SVRA SAVARA INC | Healthcare | 1.4% | $34.6m | 8,157,385 | – | |
| 23 | CGON CG ONCOLOGY INC | Healthcare | 1.2% | $29.1m | 770,000 | – | |
| 24 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 1.1% | $27.4m | 1,485,630 | – | |
| 25 | TRVI TREVI THERAPEUTICS INC | Healthcare | 1.0% | $24.7m | 7,381,090 | – | |
| 26 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.8% | $21.0m | 5,097,779 | – | |
| 27 | SLN SILENCE THERAPEUTICS PLC | 0.8% | $20.9m | 1,148,591 | – | ||
| 28 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.8% | $19.9m | 133,333 | – | |
| 29 | HILLEVAX INC | 0.7% | $18.7m | 10,617,062 | – | ||
| 30 | MERUS N V | 0.7% | $18.6m | 373,100 | – | ||
| 31 | TYRA TYRA BIOSCIENCES INC | Healthcare | 0.7% | $17.2m | 731,020 | – | |
| 32 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 0.7% | $16.8m | 4,623,324 | – | |
| 33 | ALKS ALKERMES PLC | Healthcare | 0.6% | $16.1m | 576,129 | – | |
| 34 | IMTX IMMATICS N.V | Healthcare | 0.6% | $15.5m | 1,354,711 | – | |
| 35 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 0.5% | $11.7m | 477,327 | – | |
| 36 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.5% | $11.3m | 1,250,786 | – | |
| 37 | DSGN DESIGN THERAPEUTICS INC | Healthcare | 0.4% | $10.2m | 1,892,547 | – | |
| 38 | COGT COGENT BIOSCIENCES INC | Healthcare | 0.4% | $10.1m | 936,576 | – | |
| 39 | MGNX MACROGENICS INC | Healthcare | 0.4% | $9.9m | 3,010,727 | – | |
| 40 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 0.4% | $9.6m | 689,655 | – | ||
| 41 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 0.3% | $8.0m | 2,867,750 | – | |
| 42 | PBYI PUMA BIOTECHNOLOGY INC | Healthcare | 0.3% | $7.8m | 3,062,558 | – | |
| 43 | AVU0 ADVERUM BIOTECHNOLOGIES INC | 0.3% | $7.5m | 1,069,244 | – | ||
| 44 | ETNBGBP 89BIO INC | 0.3% | $7.4m | 1,000,000 | – | ||
| 45 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 0.3% | $7.2m | 470,338 | – | |
| 46 | ARVN ARVINAS INC | Healthcare | 0.3% | $7.0m | 285,331 | – | |
| 47 | PEPG PEPGEN INC | Healthcare | 0.2% | $6.0m | 702,694 | – | |
| 48 | ELEVATION ONCOLOGY INC | 0.1% | $3.6m | 5,993,579 | – | ||
| 49 | NEWAMSTERDAM PHARMA COMPANY | 0.1% | $3.5m | 500,333 | – | ||
| 50 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 0.1% | $3.4m | 108,762 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.